Aveanna Healthcare Holdings, Inc. (AVAH) Stock
AVAH has an Alpha Score of 75 out of 100 (moderate), computed on Nov 4, 2026 from 3 of 4 sub-scores. 3 of the hedge funds AlphaScala tracks reported AVAH in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $19.59M. Company insiders reported 0 open-market buys and 9 sales on SEC Form 4 in the 90 days to Nov 10, 2026. Its trailing P/E ratio is 10.5 and its net margin 10.6% (key statistics as of Nov 11, 2026).
What is AVAH's Alpha Score?
How it works →Alpha Score of 75 reflects strong overall profile with strong momentum, strong value, moderate quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 4, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which hedge funds own AVAH?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Citadel Ken Griffin | 2.29M | $19.59M | +725% |
| Point72 Steve Cohen | 1.80M | $15.46M | +1692% |
| Renaissance Technologies Jim Simons (founder) | 816K | $6.99M | -10% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Aveanna Healthcare Holdings, Inc. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 21, 26 | Vigano Paul R | 10%+ Owner | SELL | 2.25M | $25.9M |
| Aug 21, 26 | Williams Robert M Jr | 10%+ Owner | SELL | 2.25M | $25.9M |
| Aug 21, 26 | J.H. Whitney Equity Partners Vii, Llc | 10%+ Owner | SELL | 2.25M | $25.9M |
| Aug 20, 26 | Reisz Edwin C. | Chief Administrative Officer | SELL | 50.0K | $575K |
| Aug 20, 26 | Shaner Jeff | Chief Executive Officer | SELL | 90.0K | $1.0M |
| Aug 20, 26 | Windley Rodney D | Director | SELL | 180.0K | $2.1M |
| Aug 20, 26 | Vigano Paul R | 10%+ Owner | SELL | 10.11M | $116.3M |
| Aug 20, 26 | Vigano Paul R | 10%+ Owner | SELL | 957.9K | $11.0M |
| Aug 20, 26 | Vigano Paul R | 10%+ Owner | SELL | 1.81M | $20.9M |
| Aug 20, 26 | Vigano Paul R | 10%+ Owner | SELL | 1.43M | $16.4M |
SEC Form 4 filings as of Nov 10, 2026
See cluster-buy signals across all tickers →What are AVAH's key statistics?
Key statistics as of Nov 11, 2026
How does AVAH's valuation compare with the Healthcare sector?
| Metric | AVAH | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 10.5 | 29.8 | 115 |
| Net margin | 10.56% | 3.60% | 175 |
| Return on equity | 149.76% | 2.93% | 201 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 11, 2026). P/E excludes loss-making companies.
AVAH price chart
Powered by TradingViewWhat does Aveanna Healthcare Holdings, Inc. do?
Aveanna Healthcare Holdings Inc. is a diversified home care platform specializing in services for medically complex, high-cost patient populations across the United States. It operates through three primary segments: Private Duty Services, offering skilled pediatric and adult nursing, therapy, and personal care in patients' homes; Home Health & Hospice, providing comprehensive home health and end-of-life care; and Medical Solutions, delivering enteral nutrition and related products. The company emphasizes clinical excellence, technology-enabled operations, and strong partnerships with managed care and government payers to facilitate efficient transitions from acute care settings to home environments. Aveanna Healthcare Holdings Inc. serves children and adults nationwide through an extensive network of branches, focusing on high-quality, compassionate care that reduces institutional stays and improves patient outcomes. Founded in 2016 and headquartered in Atlanta, Georgia, it stands as a national leader in addressing critical home healthcare needs with innovative solutions and data-driven results.